Unknown

Dataset Information

0

An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth.


ABSTRACT: The efficacy of traditional chemotherapy is limited by its toxicity, especially with regard to hematopoiesis. Here we show that miR-26a plays a critical role in protecting mice against chemotherapy-induced myeloid suppression by targeting a proapoptotic protein (Bak1) in hematopoietic stem/progenitor cells (HSPCs). Because c-Kit is expressed at high levels in HSPCs, we designed a microRNA-aptamer chimera that contains miR-26a mimic and c-Kit-targeting aptamer and successfully delivered miR-26a into HSPCs to attenuate toxicity of 5' fluorouracil (5-FU) and carboplatin. Meanwhile, our in silico analysis revealed widespread and prognosis-associated downregulation of miR-26a in advanced breast cancer and also showed that KIT is overexpressed among basal-like breast cancer cells and that such expression is associated with poor prognosis. Importantly, the miR-26a aptamer effectively repressed tumor growth in vivo and synergized with 5-FU or carboplatin in cancer therapy in the mouse breast cancer models. Thus, targeted delivery of miR-26a suppresses tumor growth while protecting the host against myelosuppression by chemotherapy.

SUBMITTER: Tanno T 

PROVIDER: S-EPMC5728314 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth.

Tanno Toshihiko T   Zhang Peng P   Lazarski Christopher A CA   Liu Yang Y   Zheng Pan P  

Blood advances 20170622 15


The efficacy of traditional chemotherapy is limited by its toxicity, especially with regard to hematopoiesis. Here we show that miR-26a plays a critical role in protecting mice against chemotherapy-induced myeloid suppression by targeting a proapoptotic protein (Bak1) in hematopoietic stem/progenitor cells (HSPCs). Because c-Kit is expressed at high levels in HSPCs, we designed a microRNA-aptamer chimera that contains miR-26a mimic and c-Kit-targeting aptamer and successfully delivered miR-26a i  ...[more]

Similar Datasets

| S-EPMC4089008 | biostudies-other
| S-EPMC3338807 | biostudies-literature
| S-EPMC6497993 | biostudies-literature
| S-EPMC3839688 | biostudies-literature
| S-EPMC9588748 | biostudies-literature
| S-EPMC7726969 | biostudies-literature
| S-EPMC4018137 | biostudies-literature
| S-EPMC7487335 | biostudies-literature
| S-EPMC7834050 | biostudies-literature
| S-EPMC5811376 | biostudies-literature